Heart Failure Management for NP, PA, and Primary Care Providers 2020 is organized by Mayo Clinic Cardiovascular Medicine CME (CV CME) and will be held from Mar 26 - 28, 2020 at Disney's Grand Floridian Resort & Spa, Lake Buena Vista, Florida, United States of America.
This course is appropriate for nurse practitioners, physician assistants, registered nurses, cardiologists, and primary care providers interested in an update on heart failure.
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 16.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 16.75 ANCC nursing contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Select presentations will contain pharmacology content as noted in the program. Identified presentations represent approximately 6 hours of pharmacology content.
This course delivers a comprehensive review of the diagnosis and management of heart failure across its multiple stages. Heart failure is a prevalent and costly disease causing debilitating symptoms and excess mortality. While cardiac subspecialists provide essential testing and treatment at various stages of heart failure care, the majority of patient management is handled by primary care providers. A clinical format will highlight the practice dilemmas and key management strategies essential to enhance the attendees’ confidence in caring for these challenging patients.
To reinforce the knowledge gained from the course and ensure lasting value to each attendee’s practice, Mayo Clinic provides access to all course presentations with voice-over recordings after completion of the course.
• Recognize the spectrum of signs and symptoms suspicious for heart failure
• Describe typical diagnostic testing essential for the diagnosis and management of patients with heart failure
• Apply appropriate pharmacologic and non-pharmacologic strategies for patients across the spectrum of heart failure
• Describe when referral for advanced heart failure therapies is indicated
• Demonstrate complex decision-making when renal and/or pulmonary hypertension co-exist with heart failure
|Contact No. :||800.283.6296|
|Registration Type||End Date||Price|
|MD, PhD, DO, Pharm D - Early Fee||24 Feb,2020||USD 750.00|
|MD, PhD, DO, Pharm D - Regular Fee||25 Mar,2020||USD 850.00|
|Fellow, Resident, RN, NP, PA - Early Fee||24 Feb,2020||USD 675.00|
|Fellow, Resident, RN, NP, PA - Regular Fee||25 Mar,2020||USD 775.00|